Analysis of Single-operation-hole Thoracoscopic Lobectomy in 113 Clinical Cases
10.3779/j.issn.1009-3419.2014.05.11
- VernacularTitle:单操作孔全腔镜肺癌根治术113例分析
- Author:
XU CHUN
1
;
MA HAITAO
;
NI BIN
;
HE JINGKANG
;
LI CHANG
;
DING CHENG
;
LI GUANGBIN
;
WANG YUXUAN
;
ZHAO JUN
Author Information
1. 苏州大学附属第一医院心胸外科
- Keywords:
Single-operation-hole;
Lobectomy in lung cancer resection;
Lung neoplasms
- From:
Chinese Journal of Lung Cancer
2014;(5):424-427
- CountryChina
- Language:Chinese
-
Abstract:
Background and objective Video-assisted thoracoscopic surgery (VATS) lobectomy is generally ac-cepted for patients with lung cancer. hTe aim of this study is to explore the feasibility of the single-operation-hole thoraco-scopic lobectomy in the treatment of non-small cell lung cancer. Methods To review and analyze the single-operation-hole thoracoscopic lobectomy performed in our hospital for 113 non-small cell lung cancer (NSCLC) cases from October 2010 to October 2013. hTe incision for observation was 1.5 cm the eighth intercostal at the rear of the midaxillary line and the incision for operation was 2.0 cm-4.0 cm at the fourth or iftfh intercostal of the anterior axillary line. hTe operations were performed through the single-operation-hole. Result hTe operation processes were smooth for all the patients without any operative mor-tality occurrence. Only in 5 cases was the operation hole expanded because of the occurrence of massive hemorrhage during the operation;3 patients with postoperative complications underwent thoracoscopic lobectomy again, including 2 cases of de-layed hemorrhage and 1 case of chylothorax. hTe average surgical duration was (178.24±31.17) min, the average blood loss was (213.56±62.38) mL, and the number of lymph nodes dissected was from 5-22. All diagnose were conifrmed by pathology atfer operation. hTe average length of stay was (8.17±2.93) d. All cases recovered well during the follow-up of (2-38) months, only 5 cases had recurrence or metastasis. Conclusion hTe single-operation-hole thomcoscopic lobectomy for lung cancer is safe and feasible, further reducing the trauma, and can be used as a conventional treatment for early-or medium-term NSCLC.
